The Optimal Activity of Radioactive Iodine for Remnant Ablation in Low/Intermediate Risk Differentiated Thyroid Carcinoma: A Continuous Controversy and Meta-Analysis

Radioactive iodine (RAI) is widely used for remnant ablation in low/intermediate differentiated thyroid carcinoma (DTC). However, the optimal effective dose that overweighs the benefits over unwanted side effects is a matter of controversy. This meta-analysis aimed to assess low versus high doses of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirghani, Hyder, Altidlawi, Mohammed I, Altedlawi Albalawi, Ibrahim A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885745/
https://www.ncbi.nlm.nih.gov/pubmed/33643743
http://dx.doi.org/10.7759/cureus.12937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885745/
https://www.ncbi.nlm.nih.gov/pubmed/33643743
http://dx.doi.org/10.7759/cureus.12937

Ejemplares similares